| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/08/2007 | US20070054850 Screening method |
| 03/08/2007 | US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054328 Methods |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053929 Marine algae extract and lipase inhibitor containing the same |
| 03/08/2007 | US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 03/08/2007 | CA2621227A1 Thiazole derivative |
| 03/08/2007 | CA2620687A1 Composition for diet comprising plant essential oil as active ingredient,sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof |
| 03/08/2007 | CA2620662A1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 03/08/2007 | CA2620658A1 Novel indole compounds |
| 03/08/2007 | CA2620425A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | CA2620127A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2605228A1 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 03/07/2007 | EP1760073A1 Sulfonamide compound |
| 03/07/2007 | EP1759704A2 Metal compounds, mixed or sulphated, as phosphate binders |
| 03/07/2007 | EP1759698A1 Novel method of treatment |
| 03/07/2007 | EP1759596A1 Process for producing whitish banaba extract, whitish banaba extract and food or drink containing whitish banaba extract |
| 03/07/2007 | EP1758914A1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof |
| 03/07/2007 | EP1758905A1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor |
| 03/07/2007 | EP1758891A2 Benzimidazolone carboxylic acid derivatives |
| 03/07/2007 | EP1758863A1 Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatement of diabetes |
| 03/07/2007 | EP1758853A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1758611A2 Use of liver-selective glucokinase activators |
| 03/07/2007 | EP1758597A1 Use of drug combinations for treating insulin resistance |
| 03/07/2007 | EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 03/07/2007 | EP1758590A1 Use of a detergent for the non-surgical removal of fat |
| 03/07/2007 | EP1758580A2 N-substituted piperidines and their use as pharmaceuticals |
| 03/07/2007 | EP1758575A1 Counteracting drug-induced obesity using glp-1 agonists |
| 03/07/2007 | EP1758565A2 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 03/07/2007 | EP1696902A4 Compositions containing d-tocopherol compound polybasic acid partial esters |
| 03/07/2007 | EP1521574B1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP1427411B1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo [3.1.0] hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1032387B1 Novel metal complexes |
| 03/07/2007 | EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | EP0996444B1 Treatment of diabetes with thiazolidinedione and metformin |
| 03/07/2007 | CN1926143A Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 03/07/2007 | CN1926128A Dipeptidyl peptidase inhibitors |
| 03/07/2007 | CN1926109A Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 03/07/2007 | CN1925858A Composition for treating hyperlipoidemia |
| 03/07/2007 | CN1925857A Composition for treating hyperlipoidemia |
| 03/07/2007 | CN1923813A Aporphine and use of oxidized aporphine alkaloid |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923261A Novel method for treating diabetes 'three-excessive' by nourishing liver and kidney with white peony root, Chinese yam, and siberian solomonseal rhizome |
| 03/07/2007 | CN1923236A Jinqi antihypelipidemic drops and its preparation method |
| 03/07/2007 | CN1923229A Pharmaceutical composition comprising notoginseng extract, Danshen extract and puerarin |
| 03/07/2007 | CN1923228A Pharmaceutical composition comprising notoginseng extract, Danshen extract and ligustrazine |
| 03/07/2007 | CN1923219A Nutritious agent for oral administration and externally using |
| 03/07/2007 | CN1923218A Salina algae nutrescin (nutritious agent) |
| 03/07/2007 | CN1923211A Astragaloside injection and preparation thereof |
| 03/07/2007 | CN1923210A Diructose anhydride-containing composition and use thereof |
| 03/07/2007 | CN1923207A Compound recipe vitamin freeze-dried powder for injection and its preparing process |
| 03/07/2007 | CN1303209C Synthetase-1b for human cholesterol ester and coded sequence |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1302811C Externally-applicated chewing gum including chip-like center |
| 03/07/2007 | CN1302807C Biological degradable macromolecule microspheres of carrying insulin and preparation method |
| 03/07/2007 | CN1302790C Preparation method of an arteria coronaria dialating and blood fat reducing Chinese medicine- |
| 03/07/2007 | CN1302773C Method for preparing nanometer suspension of DHA |
| 03/07/2007 | CN1302718C Body building tea bag and its preparation method |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186819 Glutamate receptor and utilization thereof |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186746 Indoles having anti-diabetic activity |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186686 Formulated composition |
| 03/06/2007 | US7186425 Administering phytic acid reduced soybean protein |
| 03/06/2007 | US7186411 Vaccines absorbable by the transmucosal way |
| 03/06/2007 | CA2389264C Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 03/06/2007 | CA2353847C Pulmonary drug delivery |
| 03/06/2007 | CA2302641C Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation |
| 03/06/2007 | CA2202228C Novel retinoids |
| 03/06/2007 | CA2191677C Cerebral function improving agents |
| 03/06/2007 | CA2189131C Use of pteridine derivatives as no-synthase inhibitors |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007025144A1 5-ht2c receptor agonists as anorectic agents |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |